VICTOR CZERKASIJ: Open Payments
NPI 1295893204 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154,317 in 396 payments from 23 companies in 2025. Trend: 2023 $79,723 · 2024 $141,877 · 2025 $154,317
Speaker / faculty: $112,056Consulting: $22,425Travel & lodging: $9,730Food & beverage: $7,566Speaker / faculty: $2,261Education: $279
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 62 | $52,231 |
| ABBVIE INC. | 31 | $17,953 |
| Arcutis Biotherapeutics, Inc. | 44 | $17,118 |
| Lilly USA, LLC | 36 | $15,092 |
| UCB, Inc. | 37 | $12,785 |
| Galderma Laboratories, L.P. | 26 | $10,739 |
| Regeneron Healthcare Solutions, Inc. | 22 | $7,120 |
| Novartis Pharmaceuticals Corporation | 37 | $6,178 |
| Kowa Pharmaceuticals America, Inc. | 7 | $5,245 |
| Eli Lilly and Company | 5 | $4,033 |
Products named: TREMFYA, Zoryve, EBGLYSS, SKYRIZI, Bimzelx, NEMLUVIO, DUPIXENT, ILUMYA.
Industry payments across GA — which companies pay providers there.
